NCT06283238View on ClinicalTrials.gov

Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 17, 2025

Primary Completion Date

March 25, 2026

Study Completion Date

March 25, 2027

Conditions
GastroEsophageal Cancer
Interventions
DRUG

Immune checkpoint inhibitor (ICI) or chemotherapy alone

Immune checkpoint inhibitor (i.e. pembrolizumab, nivolumab, or another checkpoint inhibitor) or chemotherapy alone

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT06283238 - Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON) | Biotech Hunter | Biotech Hunter